RU2002110116A - Гибридные белки, оптимизированные по субъединицам - Google Patents
Гибридные белки, оптимизированные по субъединицамInfo
- Publication number
- RU2002110116A RU2002110116A RU2002110116/13A RU2002110116A RU2002110116A RU 2002110116 A RU2002110116 A RU 2002110116A RU 2002110116/13 A RU2002110116/13 A RU 2002110116/13A RU 2002110116 A RU2002110116 A RU 2002110116A RU 2002110116 A RU2002110116 A RU 2002110116A
- Authority
- RU
- Russia
- Prior art keywords
- component
- protein
- hybrid
- hybrid protein
- milk
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims 17
- 102000004169 proteins and genes Human genes 0.000 title claims 16
- 238000000034 method Methods 0.000 claims 15
- 235000018102 proteins Nutrition 0.000 claims 15
- 108020001507 fusion proteins Proteins 0.000 claims 5
- 102000037865 fusion proteins Human genes 0.000 claims 5
- 230000009261 transgenic effect Effects 0.000 claims 5
- 108060003951 Immunoglobulin Proteins 0.000 claims 4
- 102000018358 immunoglobulin Human genes 0.000 claims 4
- 235000013336 milk Nutrition 0.000 claims 4
- 239000008267 milk Substances 0.000 claims 4
- 210000004080 milk Anatomy 0.000 claims 4
- 102000012745 Immunoglobulin Subunits Human genes 0.000 claims 3
- 108010079585 Immunoglobulin Subunits Proteins 0.000 claims 3
- 241001465754 Metazoa Species 0.000 claims 3
- 108010011756 Milk Proteins Proteins 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 230000028327 secretion Effects 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 102000014171 Milk Proteins Human genes 0.000 claims 2
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 2
- 108700019146 Transgenes Proteins 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 239000000539 dimer Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 235000021239 milk protein Nutrition 0.000 claims 2
- 238000012986 modification Methods 0.000 claims 2
- 230000004048 modification Effects 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 102000053187 Glucuronidase Human genes 0.000 claims 1
- 108010060309 Glucuronidase Proteins 0.000 claims 1
- 101000933465 Homo sapiens Beta-glucuronidase Proteins 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 108091036066 Three prime untranslated region Proteins 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 210000000069 breast epithelial cell Anatomy 0.000 claims 1
- 238000012217 deletion Methods 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- 238000013461 design Methods 0.000 claims 1
- 210000000981 epithelium Anatomy 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 210000005075 mammary gland Anatomy 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01031—Beta-glucuronidase (3.2.1.31)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3007—Carcino-embryonic Antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39907999A | 1999-09-17 | 1999-09-17 | |
| US09/399,079 | 1999-09-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2002110116A true RU2002110116A (ru) | 2004-03-10 |
Family
ID=23578058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2002110116/13A RU2002110116A (ru) | 1999-09-17 | 2000-09-18 | Гибридные белки, оптимизированные по субъединицам |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1237900A4 (enExample) |
| JP (1) | JP2003509038A (enExample) |
| KR (1) | KR20020039346A (enExample) |
| CN (1) | CN1379782A (enExample) |
| AU (1) | AU781462B2 (enExample) |
| BR (1) | BR0014524A (enExample) |
| CA (1) | CA2384766A1 (enExample) |
| HU (1) | HUP0202702A2 (enExample) |
| IL (1) | IL148549A0 (enExample) |
| MX (1) | MXPA02002768A (enExample) |
| NO (1) | NO20021244L (enExample) |
| NZ (1) | NZ517774A (enExample) |
| RU (1) | RU2002110116A (enExample) |
| WO (1) | WO2001019842A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030035798A1 (en) | 2000-08-16 | 2003-02-20 | Fang Fang | Humanized antibodies |
| CA2454358A1 (en) | 2001-07-19 | 2003-07-31 | Perlan Therapeutics, Inc. | Multimeric proteins and methods of making and using same |
| WO2015077071A1 (en) * | 2013-11-19 | 2015-05-28 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a humanized b-cell activating factor gene |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL111748A0 (en) * | 1993-12-03 | 1995-01-24 | Zeneca Ltd | Proteins |
| GB9406974D0 (en) * | 1994-04-08 | 1994-06-01 | Pharmaceutical Proteins Ltd | Transgenic production |
| US5959171A (en) * | 1994-08-17 | 1999-09-28 | Pharming B.V. | Method for the production of biologically active polypeptides in a mammal's |
| US5635363A (en) * | 1995-02-28 | 1997-06-03 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for the detection, quantitation and purification of antigen-specific T cells |
| AU6184298A (en) * | 1997-02-25 | 1998-09-09 | Genzyme Transgenics Corporation | Transgenically produced non-secreted proteins |
| GB9708918D0 (en) * | 1997-05-01 | 1997-06-25 | Ppl Therapeutics Scotland Ltd | Methods |
| CA2330527A1 (en) * | 1998-06-15 | 1999-12-23 | Genzyme Transgenics Corporation | Erythropoietin analog-human serum albumin fusion |
-
2000
- 2000-09-18 KR KR1020027003537A patent/KR20020039346A/ko not_active Ceased
- 2000-09-18 NZ NZ517774A patent/NZ517774A/en unknown
- 2000-09-18 AU AU38831/01A patent/AU781462B2/en not_active Ceased
- 2000-09-18 CN CN00814422A patent/CN1379782A/zh active Pending
- 2000-09-18 HU HU0202702A patent/HUP0202702A2/hu unknown
- 2000-09-18 EP EP00963585A patent/EP1237900A4/en not_active Withdrawn
- 2000-09-18 MX MXPA02002768A patent/MXPA02002768A/es unknown
- 2000-09-18 CA CA002384766A patent/CA2384766A1/en not_active Abandoned
- 2000-09-18 BR BR0014524-6A patent/BR0014524A/pt not_active IP Right Cessation
- 2000-09-18 JP JP2001523619A patent/JP2003509038A/ja active Pending
- 2000-09-18 RU RU2002110116/13A patent/RU2002110116A/ru unknown
- 2000-09-18 WO PCT/US2000/025558 patent/WO2001019842A1/en not_active Ceased
- 2000-09-18 IL IL14854900A patent/IL148549A0/xx unknown
-
2002
- 2002-03-13 NO NO20021244A patent/NO20021244L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001019842A1 (en) | 2001-03-22 |
| CN1379782A (zh) | 2002-11-13 |
| NO20021244L (no) | 2002-05-13 |
| HUP0202702A2 (hu) | 2002-12-28 |
| CA2384766A1 (en) | 2001-03-22 |
| NO20021244D0 (no) | 2002-03-13 |
| AU3883101A (en) | 2001-04-17 |
| EP1237900A1 (en) | 2002-09-11 |
| WO2001019842A9 (en) | 2002-11-14 |
| IL148549A0 (en) | 2002-09-12 |
| KR20020039346A (ko) | 2002-05-25 |
| BR0014524A (pt) | 2002-06-11 |
| AU781462B2 (en) | 2005-05-26 |
| NZ517774A (en) | 2005-01-28 |
| JP2003509038A (ja) | 2003-03-11 |
| EP1237900A4 (en) | 2005-08-03 |
| MXPA02002768A (es) | 2002-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2045869C (en) | Fusion proteins with immunoglobulin portions, the preparation and use thereof | |
| DK1992696T3 (da) | Circovirussekvenser forbundet med udmagringssygdom hos pattegrise (PWD). | |
| DE69332538D1 (de) | Cis elemente des ölkörperproteins als regulationische signale | |
| JPS5863390A (ja) | Ｄｎａ配列を微生物によつて発現する方法及びその生産物 | |
| RU97118361A (ru) | Трансгенные растения, экспрессирующие ген ацетил-coa-карбоксилазы | |
| JPH08506016A (ja) | トランスジェニック動物のミルク内のヒト組換えコラーゲンの製造法 | |
| US6211427B1 (en) | Peptide production as fusion protein in transgenic mammal milk | |
| ES2333724T3 (es) | Secuencias lideres para uso en la produccion de proteinas. | |
| US7045677B2 (en) | Fusion proteins incorporating lysozyme | |
| UA84666C2 (ru) | ВЫДеЛЕНнЫЙ ПОЛИНУКЛЕОТИД, КОДИРУЮЩИЙ СЛИТОЙ ПРОТЕИН С ПЕСТИЦИДНОЙ АКТИВНОСТЬЮ, И ТРАНСГЕННАЯ КЛЕТКА-ХОЗЯИН | |
| JP3789928B2 (ja) | 成長ホルモンアンタゴニスト | |
| RU2002110116A (ru) | Гибридные белки, оптимизированные по субъединицам | |
| CN1254379A (zh) | 通过使用融合蛋白生产酰胺化肽的方法 | |
| CN1055952A (zh) | 用链霉菌制备外源蛋白的方法 | |
| JP2006262875A (ja) | 鳥類の卵管内でタンパク質を発現させるための遺伝子構築物、およびこれを用いたタンパク質の生産方法 | |
| JP2008125367A (ja) | 組換えプロリン水酸化ヒトコラーゲンを生産する組換え細胞およびトランスジェニック生物 | |
| JPH05146295A (ja) | 鳥類の成長ホルモンレセプタおよび結合蛋白質 | |
| CA2437866A1 (en) | Novel clock gene bmal2 | |
| JPWO1999058662A1 (ja) | 融合タンパク質 | |
| Lee | Molecular characterization of homotrimeric types II and III collagen disorders | |
| Toman | Mouse type III procollagen gene: Cloning, DNA sequence, and expression in transgenic mice | |
| JPH0965887A (ja) | ブタ補体インヒビターをコードするｄｎａ | |
| JP2003009873A5 (enExample) |